Schirizzi, A., Renna, N., Leonardis, G. D., Montanaro, R., Mastropasqua, F., Graziano, G., . . . D’Alessandro, R. CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance. BMC.
Chicago Style (17th ed.) CitationSchirizzi, Annalisa, et al. CC48 a New CB2R Agonist/FAAH Inhibitor Dual Drug Blocks Gastric Cancer Progression and Overcomes Paclitaxel Resistance. BMC.
MLA (9th ed.) CitationSchirizzi, Annalisa, et al. CC48 a New CB2R Agonist/FAAH Inhibitor Dual Drug Blocks Gastric Cancer Progression and Overcomes Paclitaxel Resistance. BMC.
Warning: These citations may not always be 100% accurate.